Objectives: To investigate human long bone development in fetuses with intrauterine growth restriction (IUGR) by analysing distal femoral epimetaphyseal structures and bone morphometrics on prenatal MR imaging. Methods: This retrospective study included 14 fetuses (mean gestational age, 26 weeks 2 days; range, 21 weeks 3 days to 33 weeks) with IUGR caused by placental insufficiency, without other brain or body abnormalities, as well as a total of 192 age-matched normal fetuses. On 1.5-T echo-planar MR images, diaphyseal and epiphyseal morphometric measurements were assessed, and, using a grading system, the cartilaginous epiphyseal and metaphyseal shape, secondary ossification, and the perichondrium were qualitatively analysed. Student's t-testing was used to compare the morphometric measurements of IUGR fetuses with normal fetuses, and descriptive statistics were used to compare the qualitative bone characteristics. Results: The morphometric measurements of the IUGR fetuses did not exceed the minimum normative measurements at any gestational age (diaphyseal length: p <0.0001 -0.0053; epiphyseal length: p <0.0001 -0.0022; epiphyseal width: p <0.0001 -0.0032). Overall, the same grading for cartilaginous epiphyseal shape as observed in IUGR fetuses was found in 28.6% -100% of normal fetuses, for the metaphyseal shape in 7.1% -94.4%, for secondary ossification in 16.7% -100%, and for the perichondrium in 12.5%-91.7%. Conclusions: On prenatal MR imaging, fetuses with placental-based IUGR exhibit long bone shortening, whereas their qualitative bone characteristics appear within normal limits. Consequently, the presence of qualitative bone abnormalities should include the differential diagnosis of various fetal skeletal disorders.
Objectives:
The aims are(1) insight into the changes in fetal Doppler flow of early FGR and late FGR respectively by ultrasound evaluation;(2) to explore ultrasound predictor associated with pregnancy outcome. Methods: FGR was divided into early FGR (<32 weeks) and late FGR (>32 weeks) based on the time of onset. A total of 55 early FGR and 57 late FGR were recruited in our study with the normal controls established respectively. Ultrasound evaluation included fetal growth, umbilical artery (UA), heart rate (HR), fetal cardiac function (myocardial performance index, MPI and stroke volume, SV), ductus venosus (DV) and middle cerebral artery (MCA). Results: Table1 was shown Fetal Doppler flow changes for early FGR and late FGR respectively. Perinatal morbidity and mortality rate for early FGR was 23/55 (41.8%) but it was only 4/63 (6.3%) for late FGR (P value<0.05 Objectives: Studies have reported placental weight ratio (PWR) and maternal hemoglobin (Hgb) as relevant markers of uteroplacental function. Our aim was to investigate the correlations among maternal hemostasis, placental morphology, birth weight and ultrasonographic findings in normal and IUGR pregnancies. Methods: 13 patients were recruited into the case group based on their newborn's weight being below the 10th percentile and 41 patients were enrolled randomly. The placental weight and volume were measured and data were compared with the third trimester maternal blood sample. Results: PWR results were close to that described in literature, 0.14(±0.004) in the control and 0.17(±0.01) in the IUGR group p=0.0034. In placental morphometry placental volume showed the strongest correlation (R 2 =0.769), while a. umbilicalis S/D (R 2 = 0.538) and Hgb level (R 2 =0.510) showed medium correlation and placental weight showed light correlation (R 2 =0.446) with birthweight. There was significant difference between the control and IUGR groups in birthweight 3367.73g(±71.52) and 2110.04g(±155.7) p=0.0001, in a. Objectives: Our aim was to test the vasoreactivity to serotonin, a humoral factor that is present measurably. To get more detailed information we added ketanserin, a selective 5-HT2 receptor antagonist. Methods: Patients were enrolled in case and control groups based on third trimester EFW. The placenta and umbilical cord was immediately placed and stored in Krebs-Henseleit solution until the experiment (max. 24 hours). After incubation, cumulative serotonin dosage (10 -9 -10 -5 M) was added to the vessels with or without 10 -8 M ketanserin. Results: The 3DPD indices were VI=4.5 in IUGR and 10.1 in controls (p<0.001), the FI=38.5 (p<0.05) and 49.2, and the VFI=2.7 and 4.9 (p<0.01) respectively. Reactivity to serotonin considering the end point of each dose is presented in table 1. The contraction of IUGR umbilical arteries was the most powerful (p=0.03) that strongly correlated with a. umbilicalis S/D (r= 0,80, R 2 : 0,63). From the AUC values, the maximum effects (Emax) and its 50% (EC50) of serotonine were calculated, In umbilical veins EC50, in placental veins EC50 and Emax showed difference (p<0,05) between IUGR and controls. According to our preliminary results incubation with ketanserin did alter the maximal response in umbilical veins in both groups (p<0.05) but did not affect that in arteries. Conclusions: Difference of endpoint and AUC analysis depends on how fast contraction reaches its peak. In arteries ketanserin did not alter the vascular reactivity, other 5-HT receptors may dominate the regulation and in veins 5-HT2 receptor may be present more densely and can participate in reducing vascular resistance. More trend for shoulder dystocia was seen in the unknown group (7.5% vs 4.4%). The NNU admission rate was 3.7% in unknown group and 12% in known group (RR4.46 [1.06, 18.79]); all except one baby in the known group were delivered after 38 weeks. Conclusion: Results showed that known fetal macrosomia lead to more intervention. Though shoulder dystocia occurred more in unknown group but neonatal admissions were significantly less. Therefore, increase in intervention rates and consequences should be balanced against risk of shoulder dystocia. Whether a policy of actively screening for macrosomia should be pursued, is debatable as ultrasound could only correctly identify 57% babies >90th centile and 33% babies more than 95th centile.
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